Due to COVID-19 Resurgence and Institutional Net Selling... KOSPI Falls to 2270 Level

Photo by Getty Images Bank

[Asia Economy Reporter Kum Boryeong] On the 20th, the KOSPI index fell to the 2270 level, pressured by the negative factor of the resurgence of the novel coronavirus infection (COVID-19) and strong net selling by institutions and foreigners.

That afternoon, the KOSPI index closed at 2274.22, down 3.66% (86.32 points) from the previous trading day.

The KOSPI opened the session at 2339.91, down 0.87% (20.63 points) from the previous close, and widened its losses due to net selling by institutions.

In the KOSPI market, institutions and foreigners net sold 821 billion KRW and 283.7 billion KRW respectively. Although individuals net bought 1.0779 trillion KRW, it was insufficient to offset the selling pressure.

By sector, electricity & electronics (-4.19%), transportation & warehousing (-4.76%), insurance (-5.29%), and securities (-4.32%) declined, while pharmaceuticals rose by 0.14%.

Among the top 10 by market capitalization, Celltrion (0.33%) was the only stock to rise. Others such as Samsung Electronics (-4.15%), SK Hynix (-4.27%), NAVER (-3.02%), and Kakao (-3.19%) fell.

The KOSDAQ index fell 3.37% (27.60 points) to 791.14 compared to the previous trading day.

The KOSDAQ opened at 816.63, down 0.26% (2.11 points) from the previous close, briefly appeared to rebound but then fell again due to strong net selling by foreigners and institutions.

In the KOSDAQ market, foreigners and institutions net sold 188.8 billion KRW and 175 billion KRW respectively. On the other hand, individuals net bought 378.3 billion KRW.

By sector, internet (-4.08%), telecommunications equipment (-5.03%), and semiconductors (-6.13%) declined, while textiles & apparel rose by 0.28%.

Among the top 10 by market capitalization, Celltrion Pharm (1.28%) and Genexine (0.55%) rose. Conversely, Celltrion Healthcare (-0.1%), Seegene (-1.24%), Alteogen (-2.41%), and HL Biopharma (-3.42%) declined.

Researcher Lee Yesin of Shinhan Financial Investment explained, "Although liquidity and policy effects prevent the indicators from deteriorating to the level of the initial COVID-19 impact, the appearance of a reversal warrants caution."

This content was produced with the assistance of AI translation services.